Blair William & CO Agenus Inc Transaction History

Blair William & CO

$33.5 Billion
Q4 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$0.63 - $1.14 $1,260 - $2,280	2,000 Added 4.29%	48,566 $40,000
Q3 2023 Nov 09, 2023	BUY	$1.12 - $1.88 $7,728 - $12,972	6,900 Added 17.4%	46,566 $52,000
Q2 2023 Aug 11, 2023	BUY	$1.31 - $2.04 $2,620 - $4,080	2,000 Added 5.31%	39,666 $63,000
Q1 2023 May 12, 2023	BUY	$1.45 - $2.95 $5,800 - $11,800	4,000 Added 11.88%	37,666 $57,000
Q4 2022 Feb 10, 2023	BUY	$2.02 - $3.25 $2,020 - $3,250	1,000 Added 3.06%	33,666 $80,000
Q3 2022 Nov 09, 2022	SELL	$1.96 - $3.14 $10,388 - $16,642	-5,300 Reduced 13.96%	32,666 $67,000
Q2 2022 Aug 10, 2022	BUY	$1.3 - $2.64 $5,590 - $11,352	4,300 Added 12.77%	37,966 $74,000
Q1 2022 May 13, 2022	BUY	$2.35 - $3.47 $2,350 - $3,470	1,000 Added 3.06%	33,666 $83,000
Q4 2021 Feb 14, 2022	SELL	$2.92 - $5.74 $122,961 - $241,711	-42,110 Reduced 56.31%	32,666 $105,000
Q3 2021 Nov 12, 2021	SELL	$4.98 - $6.63 $59,013 - $78,565	-11,850 Reduced 13.68%	74,776 $393,000
Q2 2021 Aug 12, 2021	SELL	$2.56 - $5.49 $39,424 - $84,546	-15,400 Reduced 15.09%	86,626 $476,000
Q1 2021 May 13, 2021	BUY	$2.69 - $5.25 $112,173 - $218,925	41,700 Added 69.12%	102,026 $278,000
Q4 2020 Feb 09, 2021	BUY	$3.17 - $4.49 $9,034 - $12,796	2,850 Added 4.96%	60,326 $192,000
Q3 2020 Nov 06, 2020	SELL	$2.98 - $5.2 $1,043 - $1,820	-350 Reduced 0.61%	57,476 $230,000
Q2 2020 Aug 12, 2020	BUY	$2.29 - $4.24 $458 - $848	200 Added 0.35%	57,826 $227,000
Q1 2020 May 11, 2020	SELL	$1.92 - $4.39 $20,321 - $46,463	-10,584 Reduced 15.52%	57,626 $141,000
Q4 2019 Feb 13, 2020	BUY	$2.41 - $4.4 $25,064 - $45,760	10,400 Added 17.99%	68,210 $278,000
Q3 2019 Nov 12, 2019	BUY	$2.17 - $3.14 $1,953 - $2,826	900 Added 1.58%	57,810 $149,000
Q1 2019 May 14, 2019	SELL	$2.51 - $3.73 $3,764 - $5,595	-1,500 Reduced 2.57%	56,910 $169,000
Q4 2018 Feb 14, 2019	SELL	$1.59 - $2.66 $9,937 - $16,625	-6,250 Reduced 9.67%	58,410 $139,000
Q3 2018 Nov 13, 2018	BUY	$1.59 - $2.42 $9,937 - $15,125	6,250 Added 10.7%	64,660 $138,000
Q2 2018 Aug 13, 2018	BUY	$2.26 - $4.65 $21,695 - $44,640	9,600 Added 19.67%	58,410 $133,000
Q1 2018 May 15, 2018	BUY	$3.51 - $6.04 $54,440 - $93,680	15,510 Added 46.58%	48,810 $230,000
Q4 2017 Feb 14, 2018	SELL	$3.26 - $4.78 $652 - $956	-200 Reduced 0.6%	33,300 $109,000
Q3 2017 Nov 13, 2017	BUY	$3.48 - $4.44 $116,580 - $148,740	33,500	33,500 $148,000

Others Institutions Holding AGEN

# of Institutions

Shares Held

Call Options Held

Put Options Held

View Full List

About AGENUS INC

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

More about AGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Blair William & CO, based on Form 13F filings with the SEC.

News

Stay updated on Blair William & CO with notifications on news.

Account